Stay updated on Pfizer Press Releases

Sign up to get notified when there's something new on the Pfizer Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Pfizer Press Releases page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a dedicated Press Release Archive page and removed the Press Releases and News navigation options, restructuring how press content is accessed.
    Difference
    0.4%
    Check dated 2026-04-02T15:30:31.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Adds four March 2026 press releases to the archive and removes older January–February 2026 entries.
    Difference
    8%
    Check dated 2026-03-26T11:30:44.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Research and Research and Pipeline categories and included the March 17, 2026 press release Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer. Removed Finance and Financial categories and deleted the February 3 conference call webcast entry from December 2025.
    Difference
    2%
    Check dated 2026-03-19T05:07:34.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a March 9, 2026 press release titled Pfizer’s Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis under the Research category. Removed the December 17, 2025 press release ‘PADCEV™ Plus Keytruda® Significantly Improves Survival for Patients with Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility’ from the archive.
    Difference
    2%
    Check dated 2026-03-11T23:28:03.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added the PADCEV™ + Keytruda® press release dated 02.27.2026 under Medicines and Research and Pipeline; added the corresponding category links. Removed the December 16, 2025 press release 'Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance' from the archive.
    Difference
    1%
    Check dated 2026-03-05T00:51:35.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Two new press releases have been added to the archive: 'Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference' (02.23.2026) and 'U.S. FDA Grants Full Approval to Pfizer’s BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer' (02.24.2026). Older items were removed: 'TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer' (12.10.2025) and 'Pfizer Declares First-Quarter 2026 Dividend' (12.12.2025).
    Difference
    3%
    Check dated 2026-02-25T20:09:11.000Z thumbnail image

Stay in the know with updates to Pfizer Press Releases

Enter your email address, and we'll notify you when there's something new on the Pfizer Press Releases page.